<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04221048</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL19_0591</org_study_id>
    <nct_id>NCT04221048</nct_id>
  </id_info>
  <brief_title>Accuracy of Risk Prediction Scores in Pregnant Women</brief_title>
  <acronym>PREG-GUCH</acronym>
  <official_title>Accuracy of Risk Prediction Scores in Pregnant Women With Congenital Heart Disease.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Management of pregnancy and risk stratification in congenital heart disease (CHD) population
      might be challenging especially due to physiological haemodynamic modifications that
      inevitably occur during pregnancy. We aim to compare the accuracy of the main published
      scores including CARPREG II score in prediction of maternal complications during pregnancy in
      CHD patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since the end of the 20th century, surgical and medical care progresses have significantly
      improved prognosis and quality of life of patients with congenital heart diseases (CHD).
      Currently, women with CHD expect to experience a &quot;normal&quot; life and express a strong maternity
      desire.

      During the last decade, several scores have been used to predict outcome of pregnancy in
      women with cardiovascular heart diseases. It has been suggested that the mWHO classification
      was more appropriate than the previous ones (e.g. Harris, Zahara and CAPREG classifications)
      in predicting cardiac complications in CHD. More recently, a new risk score stratification
      (CARPREG II) have been published to improve maternal risk stratification.

      This retrospective study will include all pregnant women with CHD who were follow up in our
      institution from January 2007 to June 2018 until 6 months postpartum. The investigators will
      collect demographic and clinical data, type and complexity of CHD (Houyel and Bethesda
      classification), and pregnancy outcomes. Pregnancy scores will be based on information
      obtained from the relevant clinical letter and clinical notes. The discriminatory power of
      each risk scores was assessed by the area-under-the receiver-operating characteristic (ROC)
      curve (AUC). In order to assess the reproducibility of scores classification assigned to CHD
      patients, all pregnancy scores from this cohort were assessed by 3 independent observers and,
      thereafter, estimated Cronbach's coefficient alpha.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 30, 2018</start_date>
  <completion_date type="Actual">October 30, 2019</completion_date>
  <primary_completion_date type="Actual">October 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Cardiovascular complications</measure>
    <time_frame>From the 20th week of gestation until 6 months post partum</time_frame>
    <description>Cardiovascular complications during pregnancy until 6 months post partum</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">70</enrollment>
  <condition>Congenital Heart Disease</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>PREG-GUCH</arm_group_label>
    <description>Pregnant women with congenital heart diseases</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Retrospective observational</intervention_name>
    <description>Pregnancy scores will be based on information obtained from the relevant clinical letter and clinical notes</description>
    <arm_group_label>PREG-GUCH</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with congenital heart diseases who delivered at Montpellier Universityhospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        - All patients with congenital heart diseases who deliver in our institution during the
        study period

        Exclusion criteria:

        - Women with acquired cardiovascular diseases
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pascal AMEDRO, MD-PhD</last_name>
    <role>Study Director</role>
    <affiliation>UH MONTPELLIER</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uh Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010 Sep 28;56(14):1149-57. doi: 10.1016/j.jacc.2010.03.085.</citation>
    <PMID>20863956</PMID>
  </reference>
  <reference>
    <citation>Harris IS. Management of pregnancy in patients with congenital heart disease. Prog Cardiovasc Dis. 2011 Jan-Feb;53(4):305-11. doi: 10.1016/j.pcad.2010.08.001. Review.</citation>
    <PMID>21295672</PMID>
  </reference>
  <reference>
    <citation>Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJ, Vliegen HW, van Dijk AP, Voors AA, Yap SC, van Veldhuisen DJ, Pieper PG; ZAHARA Investigators. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010 Sep;31(17):2124-32. doi: 10.1093/eurheartj/ehq200. Epub 2010 Jun 28.</citation>
    <PMID>20584777</PMID>
  </reference>
  <reference>
    <citation>Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg MJ. Pregnancy outcomes in women with congenital heart disease. Circulation. 2006 Jan 31;113(4):517-24.</citation>
    <PMID>16449731</PMID>
  </reference>
  <reference>
    <citation>Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA; ESC Scientific Document Group . 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340.</citation>
    <PMID>30165544</PMID>
  </reference>
  <reference>
    <citation>Fu Q, Lin J. Predictive accuracy of three clinical risk assessment systems for cardiac complications among Chinese pregnant women with congenital heart disease. Int J Gynaecol Obstet. 2016 Aug;134(2):140-4. doi: 10.1016/j.ijgo.2016.02.010. Epub 2016 Apr 22.</citation>
    <PMID>27177511</PMID>
  </reference>
  <reference>
    <citation>Pijuan-Domènech A, Galian L, Goya M, Casellas M, Merced C, Ferreira-Gonzalez I, Marsal-Mora JR, Dos-Subirà L, Subirana-Domènech MT, Pedrosa V, Baró-Marine F, Manrique S, Casaldàliga-Ferrer J, Tornos P, Cabero L, Garcia-Dorado D. Cardiac complications during pregnancy are better predicted with the modified WHO risk score. Int J Cardiol. 2015 Sep 15;195:149-54. doi: 10.1016/j.ijcard.2015.05.076. Epub 2015 May 15.</citation>
    <PMID>26043149</PMID>
  </reference>
  <reference>
    <citation>Cianfarani F, Masse D, Vallat G, Cano N, Guimars C, Glezer D. [The role of Regional Penitentiary Medico-Psychological Centers in the French system of aid to mental patients]. Acta Med Leg Soc (Liege). 1986;36(2):191-8. French.</citation>
    <PMID>2979363</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 6, 2020</study_first_submitted>
  <study_first_submitted_qc>January 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 9, 2020</study_first_posted>
  <last_update_submitted>January 8, 2020</last_update_submitted>
  <last_update_submitted_qc>January 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Risk score</keyword>
  <keyword>Maternal complication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

